Major research findings
- Pharmacokinetics of repeated doses of misoprostol
- Rates of Serious Infection after Changes in Regimens for Medical Abortion
- Mifepristone-induced abortion and placental complications in subsequent pregnancy
- Two distinct oral routes of Misoprostol in Mifepristone medical abortion: a randomized controlled trial
- Ibuprofen and Paracetamol for pain relief during medical abortion: a duble-blind randomized controlled study
- Reducing maternal mortality due to elective abortion: potential impact of Misoprostol in low-resource setting
- Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center
- Medical abortion and the risk of subsequent adverse pregnancy outcomes
- Alternatives to Mifepristone for early medical abortion
- Misoprostol use in obstetric and gynecology in Brazil, Jamaica, and the United States
- Misoprostol use in developing countries: results from a multicountry study
- Comparison of two doses and two routes of administration of Misoprostol after pre-treatment with Mifepristone for early pregnancy termination
- Accounting for time: insights from a life-table analysis of the efficacy of medical abortion
- Verifying the effectiveness of medical abortion: ultrasound versus hCG testing
- Feasibility, efficacy, safety, and acceptability of mifepristone–misoprostol for medical
abortion in the Democratic People's Republic of Korea
Top of the page
